Gossamer Bio (GOSS) Equity Ratio: 2022-2025
Historic Equity Ratio for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -0.39.
- Gossamer Bio's Equity Ratio fell 355.55% to -0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.39, marking a year-over-year decrease of 355.55%. This contributed to the annual value of 0.09 for FY2024, which is 53.52% down from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Equity Ratio is -0.39, which was down 106.02% from -0.19 recorded in Q2 2025.
- Over the past 5 years, Gossamer Bio's Equity Ratio peaked at 0.30 during Q3 2023, and registered a low of -0.39 during Q3 2025.
- For the 3-year period, Gossamer Bio's Equity Ratio averaged around -0.00, with its median value being 0.09 (2024).
- Examining YoY changes over the last 5 years, Gossamer Bio's Equity Ratio showed a top increase of 353.98% in 2023 and a maximum decrease of 416.06% in 2023.
- Over the past 4 years, Gossamer Bio's Equity Ratio (Quarterly) stood at 0.04 in 2022, then surged by 353.98% to 0.20 in 2023, then slumped by 53.52% to 0.09 in 2024, then slumped by 355.55% to -0.39 in 2025.
- Its Equity Ratio was -0.39 in Q3 2025, compared to -0.19 in Q2 2025 and -0.02 in Q1 2025.